LOKELMA 10 G
SODIUM ZIRCONIUM CYCLOSILICATE : 10 G · DIN 02490722 · ASTRAZENECA CANADA INC
Health Canada status: MARKETED
What is LOKELMA?
LOKELMA 10 G contains SODIUM ZIRCONIUM CYCLOSILICATE : 10 G. It is listed in the Health Canada Drug Product Database under DIN 02490722, held by ASTRAZENECA CANADA INC, supplied as POWDER FOR SUSPENSION for ORAL administration. Health Canada currently lists it as marketed, status dated 17-Oct-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LOKELMA used for?
LOKELMA (sodium zirconium cyclosilicate powder for oral suspension) is indicated for the treatment of hyperkalemia in adult patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02490722 |
|---|---|
| Brand name | LOKELMA |
| Generic / active ingredient | SODIUM ZIRCONIUM CYCLOSILICATE : 10 G |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 10 G |
| Dosage form | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | V03AE10 SODIUM ZIRCONIUM CYCLOSILICATE |
| AHFS class | 38:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 17-Oct-2019 |
| Original market date | 2020-02-06 00:00:00 |
How is it stored and handled?
null
How is it supplied?
LOKELMA 5 g is available in cartons of 30 sachets. LOKELMA 10 g is available in cartons of 3 or 30 sachets.
Is SODIUM ZIRCONIUM CYCLOSILICATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code V03AE10 SODIUM ZIRCONIUM CYCLOSILICATE. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LOKELMA | 5 G | POWDER FOR SUSPENSION | ASTRAZENECA CANADA INC | MARKETED | DIN 02490714 |
Who else supplies SODIUM ZIRCONIUM CYCLOSILICATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SODIUM ZIRCONIUM CYCLOSILICATE appears in 5432 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.